NutraMax repurchasing 47% of its outstanding stock from Mediq.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX BUYBACK OF 47% OF OUTSTANDING STOCK FROM MEDIQ for $9 a share was announced by the private label company Sept. 9. The repurchase agreement "concludes a comprehensive process that began more than one year ago, and will eliminate the overhang in the stock created by" ownership by the medical equipment supplier, NutraMax President and CEO Donald Lepone said.